Key result
A low TAPSE/PASP ratio (<0.38 mm/mmHg) was associated with maladaptive ventricular remodeling and was an independent predictor of higher mortality in patients with cardiomyopathy.
Why the study?
To evaluate the prognostic utility of TAPSE/PASP as an echocardiographic marker of maladaptive RV remodeling using CMR, and compare it to TAPSE alone in cardiomyopathy.
Does the TAPSE/PASP ratio predict maladaptive remodeling and mortality in patients with ischemic and non-ischemic cardiomyopathy?
Cohort (n=332)
Does the TAPSE/PASP ratio predict maladaptive remodeling and mortality in patients with ischemic and non-ischemic cardiomyopathy?
The TAPSE/PASP ratio is a useful echocardiographic marker that predicts maladaptive ventricular remodeling and mortality in patients with cardiomyopathy.
May aid risk stratification in cardiomyopathy; extends echo parameters but remains hypothesis-generating pending validation.
The main aim of this study was to assess the prognostic utility of TAPSE/PASP as an echocardiographic parameter of maladaptive RV remodeling in cardiomyopathy patients using cardiac magnetic resonance (CMR) imaging. Furthermore, we sought to compare TAPSE/PASP to TAPSE. The association of the echocardiographic parameters TAPSE/PASP and TAPSE with CMR parameters of RV and LV remodeling was evaluated in 111 patients with ischemic and non-ischemic cardiomyopathy and cut-off values for maladaptive RV remodeling were defined. In a second step, the prognostic value of TAPSE/PASP and its cut-off value were analyzed regarding mortality in a validation cohort consisting of 221 patients with ischemic and non-ischemic cardiomyopathy. A low TAPSE/PASP (<0.38 mm/mmHg) and TAPSE (<16 mm) were associated with a lower RVEF and a long-axis RV global longitudinal strain (GLS) as well as higher RVESVI, RVEDVI and NT-proBNP. A low TAPSE/PASP, but not TAPSE, was associated with a lower LVEF and long-axis LV GLS, and a higher LVESVI, LVEDVI and T1 relaxation time at the interventricular septum and the RV insertion points. Furthermore, in the validation cohort, low TAPSE/PASP was associated with a higher mortality and TAPSE/PASP was an independent predictor of mortality. TAPSE/PASP is a predictor of maladaptive RV and LV remodeling associated with poor outcomes in cardiomyopathy patients.
No takes yet. Share an insight, caveat, or question.
Keranov et al. (2021) conducted a cohort in Ischemic and non-ischemic cardiomyopathy (n=332). Low TAPSE/PASP ratio (<0.38 mm/mmHg) vs. Higher TAPSE/PASP ratio was evaluated on Mortality and maladaptive RV and LV remodeling. A low TAPSE/PASP ratio (<0.38 mm/mmHg) was associated with maladaptive ventricular remodeling and was an independent predictor of higher mortality in patients with cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: